Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddy’s Lab loses patent case with Eli Lilly

Date: 25-06-2018

Dr. Reddy’s Laboratories has lost a legal battle with Eli Lilly and Company in a patent litigation on Alimta (pemetrexed for injection), a drug used for treatment of various types of cancer, in the USA. The US District Court for the Southern District of Indiana ruled in favor of Lilly.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.